The ROE (Return on Equity) of Lexicon Pharmaceuticals Inc (LXRX) is -137.31%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -137.31% |
| 2023-12-31 | -190.23% |
| 2022-12-31 | -87.02% |
| 2021-12-31 | -77.29% |
| 2020-12-31 | -37.47% |
| 2019-12-31 | 111.10% |
| 2018-12-31 | 456.44% |
| 2017-12-31 | -180.09% |
| 2016-12-31 | -83.48% |
| 2015-12-31 | -1.64% |